咚咚
Lv411
536 积分
2025-03-03 加入
-
The industrial design, translation, and development strategies for long-acting peptide delivery
2小时前
已完结
-
Preparation of semaglutide long-acting injectable microcapsules with physicochemical properties, long-term stability, and pharmacokinetics and pharmacodynamics
8小时前
已完结
-
Design, synthesis and evaluation of (E)-1-(4-(2-(1H-pyrazol-5-yl)vinyl)phenyl) derivatives as next generation selective RET inhibitors overcoming RET solvent front mutations (G810C/R)
14天前
已完结
-
Discovery of 4-methyl-N-(4-((4-methylpiperazin- 1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-oxy)benzamide as a potent inhibitor of RET and its gatekeeper mutant
14天前
已完结
-
1-Methyl-3-((4-(quinolin-4-yloxy)phenyl)amino)-1H-pyrazole-4-carboxamide derivatives as new rearranged during Transfection (RET) kinase inhibitors capable of suppressing resistant mutants in solvent-front regions
14天前
已完结
-
Thirty Years of Progress Thanks to the RET Oncogene
14天前
已完结
-
Selective RET Kinase Inhibitors and Lung Cancer
14天前
已完结
-
Selpercatinib or Chemotherapy in RET Fusion–Positive NSCLC
14天前
已完结
-
Discovery of 7-(1-methyl-1H-pyrazol-4-yl)-1,6-naphthyridine Derivatives as Potent Inhibitors of Rearranged During Transfection (RET) and RET Solvent-Front Mutants for Overcoming Selpercatinib Resistance
14天前
已完结
-
[Tetracycline complexes. Study of 1-1 complexes of iron III, cobalt II, copper II and nickel II with tetracycline, oxytetracycline, demeclocycline, doxycycline and minocycline]
15天前
已关闭